Morel DR - Search Results

1

Objective and subjective evaluation of endoscopic nasal surgery outcomes.

Giger R, Landis BN, Zheng C, Malis DD, Ricchetti A, Kurt AM, Morel DR, Lacroix JS. Giger R, et al. Among authors: morel dr. Am J Rhinol. 2003 Nov-Dec;17(6):327-33. Am J Rhinol. 2003. PMID: 14750607

2

Intranasal administration of neuropeptide Y in man: systemic absorption and functional effects.

Lacroix JS, Ricchetti AP, Morel D, Mossimann B, Waeber B, Grouzmann E. Lacroix JS, et al. Br J Pharmacol. 1996 Aug;118(8):2079-84. doi: 10.1111/j.1476-5381.1996.tb15647.x. Br J Pharmacol. 1996. PMID: 8864546 Free PMC article. Clinical Trial.

3

Influence of TASP-V, a novel neuropeptide Y (NPY) Y2 agonist, on nasal and bronchial responses evoked by histamine in anaesthetized pigs and in humans.

Malis DD, Grouzmann E, Morel DR, Mutter M, Lacroix JS. Malis DD, et al. Among authors: morel dr. Br J Pharmacol. 1999 Feb;126(4):989-96. doi: 10.1038/sj.bjp.0702388. Br J Pharmacol. 1999. PMID: 10193779 Free PMC article. Clinical Trial.

4

Modulatory effect of two novel CGRP receptor antagonists on nasal vasodilatatory responses to exogenous CGRP, capsaicin, bradykinin and histamine in anaesthetised pigs.

Malis DD, Rist B, Nicoucar K, Beck-Sickinger AG, Morel DR, Lacroix JS. Malis DD, et al. Among authors: morel dr. Regul Pept. 2001 Sep 15;101(1-3):101-8. doi: 10.1016/s0167-0115(01)00275-0. Regul Pept. 2001. PMID: 11495685

5

Somato-sympathetic vasoconstriction to intranasal fluid administration with consecutive decrease in nasal nitric oxide.

Landis BN, Beghetti M, Morel DR, Giger R, Rimensberger PC, Lacroix JS. Landis BN, et al. Among authors: morel dr. Acta Physiol Scand. 2003 Apr;177(4):507-15. doi: 10.1046/j.1365-201X.2003.01099.x. Acta Physiol Scand. 2003. PMID: 12648168

6

Loss of dipeptidylpeptidase IV activity in chronic rhinosinusitis contributes to the neurogenic inflammation induced by substance P in the nasal mucosa.

Grouzmann E, Monod M, Landis B, Wilk S, Brakch N, Nicoucar K, Giger R, Malis D, Szalay-Quinodoz I, Cavadas C, Morel DR, Lacroix JS. Grouzmann E, et al. Among authors: morel dr. FASEB J. 2002 Jul;16(9):1132-4. doi: 10.1096/fj.01-0939fje. Epub 2002 May 21. FASEB J. 2002. PMID: 12039843

7

Implication of dipeptidylpeptidase IV activity in human bronchial inflammation and in bronchoconstriction evaluated in anesthetized rabbits.

Landis BN, Grouzmann E, Monod M, Busso N, Petak F, Spiliopoulos A, Robert JH, Szalay-Quinodoz I, Morel DR, Lacroix JS. Landis BN, et al. Among authors: morel dr. Respiration. 2008;75(1):89-97. doi: 10.1159/000106267. Epub 2007 Jul 18. Respiration. 2008. PMID: 17637510

8

Vascular control of the pig nasal mucosa: distribution and effect of somatostatin in relation to noradrenaline and neuropeptide Y.

Lacroix JS, Auberson S, Morel DR, Theodorsson E, Hökfelt T, Lundberg JM. Lacroix JS, et al. Among authors: morel dr. Regul Pept. 1992 Aug 13;40(3):373-87. doi: 10.1016/0167-0115(92)90524-x. Regul Pept. 1992. PMID: 1359611

9

Different effects of prostacyclin and phentolamine on delivery-dependent O2 consumption and skin microcirculation after cardiac surgery.

Pittet JF, Lacroix JS, Gunning K, Déom A, Neidhart P, Morel DR, Suter PM. Pittet JF, et al. Among authors: morel dr. Can J Anaesth. 1992 Dec;39(10):1023-9. doi: 10.1007/BF03008369. Can J Anaesth. 1992. PMID: 1464127

10

Time course of plasma and pulmonary lymph endothelin-like immunoreactivity during sustained endotoxaemia in chronically instrumented sheep.

Morel DR, Pittet JF, Gunning K, Hemsen A, Lacroix JS, Lundberg JM. Morel DR, et al. Clin Sci (Lond). 1991 Sep;81(3):357-65. doi: 10.1042/cs0810357. Clin Sci (Lond). 1991. PMID: 1655337

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters